On January 21, 2026, the New Jersey Appellate Division rejected a physician’s appeal concerning an Order of the Board of Medical Examiners dated April 19, 2024 enforcing a prior Consent Order that had been entered on March 14, 2007. The 2007 Consent Order had required the respondent physician to be accompanied by a chaperone
Commercial property owners, including healthcare entities, can learn more about the process for filing a 2026 property tax appeal and related deadlines in this Client Alert from our real estate team.
New Jersey’s regulatory landscape may be frozen—but healthcare compliance risks are anything but. Governor Mikie Sherrill’s Executive Order 7 imposes a 90-day pause on new rulemaking, while former Governor Murphy’s termination of pandemic-era regulatory flexibilities is still set to take effect on February 16, 2026. For certain healthcare providers, these overlapping executive actions create uncertainty—but
New Jersey will fully exit its pandemic-era regulatory framework for certain healthcare providers on February 16, 2026. As outlined in this recent client alert by Greenbaum attorney Sukrti Thonse, impacted providers – including Advanced Practice Nurses, Physician Assistants, hospitals, medical practices, and providers operating under emergency or reciprocity licenses – should take action now to
Two lessons emerge from the Appellate Division’s December 5, 2025 opinion in Weissman v. Li. The first is a reiteration of the importance of precision of the language used in questioning witnesses. The other is rejection of the reflexive reluctance to question one’s own witness in a pretrial deposition.
This is a medical malpractice
On November 12, 2025, President Donald Trump signed, legislation, H.R. 5371, extending key Medicare telehealth flexibilities on a temporary basis through January 1, 2026. Our previous client alert outlined the immediate rollback of pandemic-era telehealth rules following the government shutdown and the resulting disruption. This new legislation temporarily reverses that rollback and restores the
On May 12, 2025, President Donald Trump issued an Executive Order (EO) entitled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” with the goal of ensuring Americans pay no more for prescription drugs than other developed nations.
The EO directed the Secretary of Health and Human Services to communicate most-favored-nation (MFN) price targets to manufacturers
California has enacted two bills that will significantly impact private equity firms, management services organizations (MSOs), and physician practices operating in the state.
Assembly Bill 1415 (AB 1415) and Senate Bill 351 (SB 351) build on longstanding concerns about the corporate practice of medicine (CPOM) by expanding regulatory oversight of transactions and strengthening statutory prohibitions
Among the many ripples from the current government shutdown is a sudden rollback of telehealth flexibilities under Medicare that will impact both providers and beneficiaries. Greenbaum partner John Kaveney provides an overview of key issues for healthcare entities in this recently published Client Alert.
